InsiderTrades.com logo

BMRN Insider Trading

Insider Ownership Percentage: 0.85%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $308,171.94

BioMarin Pharmaceutical Insider Trading History Chart

This chart shows the insider buying and selling history at BioMarin Pharmaceutical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BioMarin Pharmaceutical Share Price & Price History

Current Price: $53.82
Price Change: ▼ Price Decrease of -0.49 (-0.90%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for BMRN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

BioMarin Pharmaceutical Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/20/2025Erin BurkhartCAOSell1,786$59.31$105,927.6614,173View SEC Filing Icon  
5/2/2025Cristin HubbardEVPSell273$64.92$17,723.1632,700View SEC Filing Icon  
3/19/2025Erin BurkhartCAOSell1,295$71.52$92,618.4016,955View SEC Filing Icon  
2/24/2025Erin BurkhartCAOSell1,344$68.38$91,902.7213,105View SEC Filing Icon  
11/12/2024Charles Greg GuyerEVPSell5,278$66.37$350,300.8668,909View SEC Filing Icon  
5/30/2024Brian R. MuellerCFOSell5,000$75.19$375,950.0072,159View SEC Filing Icon  
5/28/2024George Eric DavisEVPSell40,850$74.51$3,043,733.5056,157View SEC Filing Icon  
5/9/2024Jean Jacques BienaimeDirectorSell20,000$81.62$1,632,400.00474,994View SEC Filing Icon  
5/2/2024George Eric DavisEVPSell1,850$85.01$157,268.5056,157View SEC Filing Icon  
4/12/2024Jean Jacques BienaimeDirectorSell20,000$91.26$1,825,200.00474,994View SEC Filing Icon  
4/10/2024Erin BurkhartCAOSell2,286$90.00$205,740.0016,156View SEC Filing Icon  
3/28/2024George Eric DavisEVPSell24,602$88.34$2,173,340.6855,856View SEC Filing Icon  
3/5/2024Henry J. FuchsInsiderSell35,341$85.18$3,010,346.38212,117View SEC Filing Icon  
3/5/2024Jean Jacques BienaimeDirectorSell1,000$85.51$85,510.00561,203View SEC Filing Icon  
3/5/2024Jeffrey Robert AjerEVPSell4,000$87.07$348,280.0094,047View SEC Filing Icon  
2/27/2024Jean Jacques BienaimeDirectorSell1,000$90.35$90,350.00562,203View SEC Filing Icon  
2/9/2024Jean Jacques BienaimeDirectorSell15,000$88.28$1,324,200.00419,602View SEC Filing Icon  
1/9/2024Jean Jacques BienaimeDirectorSell10,000$98.19$981,900.00425,162View SEC Filing Icon  
12/21/2023Jean Jacques BienaimeDirectorSell10,000$93.99$939,900.00425,112View SEC Filing Icon  
12/13/2023George Eric DavisEVPSell13,764$95.30$1,311,709.2055,710View SEC Filing Icon  
8/16/2023Jeffrey Robert AjerEVPSell5,000$90.00$450,000.0060,804View SEC Filing Icon  
8/10/2023Henry J. FuchsInsiderSell12,000$90.43$1,085,160.00176,187View SEC Filing Icon  
8/8/2023George Eric DavisEVPSell11,000$89.42$983,620.0069,474View SEC Filing Icon  
8/7/2023Jean Jacques BienaimeCEOSell4,000$88.10$352,400.00428,732View SEC Filing Icon  
5/10/2023Jean Jacques BienaimeCEOSell30,000$94.85$2,845,500.00426,213View SEC Filing Icon  
4/10/2023Jean Jacques BienaimeCEOSell10,000$99.56$995,600.00425,896View SEC Filing Icon  
4/6/2023Jean Jacques BienaimeCEOSell10,000$96.13$961,300.00425,896View SEC Filing Icon  
4/3/2023V. Bryan LawlisDirectorSell8,500$97.09$825,265.0028,950View SEC Filing Icon  
3/13/2023Jean Jacques BienaimeCEOSell8,000$90.45$723,600.00487,856View SEC Filing Icon  
3/10/2023Jean Jacques BienaimeCEOSell15,000$92.28$1,384,200.00487,856View SEC Filing Icon  
2/13/2023Jean Jacques BienaimeCEOSell6,000$109.15$654,900.00320,324View SEC Filing Icon  
2/10/2023Jean Jacques BienaimeCEOSell15,000$110.11$1,651,650.00320,324View SEC Filing Icon  
1/25/2023Jeffrey Robert AjerEVPSell49,000$115.70$5,669,300.0041,088View SEC Filing Icon  
1/17/2023Jean Jacques BienaimeCEOSell10,000$111.55$1,115,500.00320,424View SEC Filing Icon  
1/13/2023Brian R. MuellerCFOSell2,500$114.50$286,250.0027,746View SEC Filing Icon  
1/13/2023Jean Jacques BienaimeCEOSell10,000$112.25$1,122,500.00320,424View SEC Filing Icon  
12/13/2022Brian R. MuellerCFOSell2,500$107.50$268,750.0027,746View SEC Filing Icon  
12/13/2022Jean Jacques BienaimeCEOSell1,000$106.89$106,890.00320,424View SEC Filing Icon  
12/2/2022Brian R. MuellerCFOSell7,001$104.50$731,604.5027,746View SEC Filing Icon  
12/2/2022Jean Jacques BienaimeCEOSell1,500$103.98$155,970.00321,424View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for BioMarin Pharmaceutical (NASDAQ:BMRN)

98.71% of BioMarin Pharmaceutical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BMRN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

BioMarin Pharmaceutical Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/2/2025Allworth Financial LP4,201$0.23M0.0%+58.9%0.002%Search for SEC Filing on Google Icon
12/2/2025IFP Advisors Inc2,373$0.13M0.0%+35.7%0.001%Search for SEC Filing on Google Icon
12/2/2025Swiss Life Asset Management Ltd20,285$1.10M0.0%-72.8%0.011%Search for SEC Filing on Google Icon
11/21/2025CIBC Bancorp USA Inc.6,876$0.37M0.0%N/A0.004%Search for SEC Filing on Google Icon
11/20/2025Caerus Investment Advisors LLC9,958$0.54M0.2%N/A0.005%Search for SEC Filing on Google Icon
11/19/2025Captrust Financial Advisors47,461$2.57M0.0%+20.5%0.025%Search for SEC Filing on Google Icon
11/19/2025Coldstream Capital Management Inc.10,487$0.57M0.0%+73.1%0.005%Search for SEC Filing on Google Icon
11/19/2025Danske Bank A S115,624$6.26M0.0%N/A0.060%Search for SEC Filing on Google Icon
11/19/2025Caitong International Asset Management Co. Ltd737$40K0.0%N/A0.000%Search for SEC Filing on Google Icon
11/17/2025NewEdge Advisors LLC24,331$1.32M0.0%+23.7%0.013%Search for SEC Filing on Google Icon
11/17/2025Krensavage Asset Management LLC405,450$21.96M9.4%N/A0.211%Search for SEC Filing on Google Icon
11/17/2025CANADA LIFE ASSURANCE Co167,032$9.02M0.0%+2.3%0.087%Search for SEC Filing on Google Icon
11/17/2025XTX Topco Ltd20,267$1.10M0.1%N/A0.011%Search for SEC Filing on Google Icon
11/17/2025Voleon Capital Management LP65,781$3.56M0.1%+1,497.0%0.034%Search for SEC Filing on Google Icon
11/17/2025Voloridge Investment Management LLC601,046$32.55M0.1%-41.2%0.313%Search for SEC Filing on Google Icon
11/17/2025Verition Fund Management LLC156,745$8.49M0.0%-46.2%0.082%Search for SEC Filing on Google Icon
11/17/2025Vestal Point Capital LP830,000$44.95M2.0%+66.0%0.432%Search for SEC Filing on Google Icon
11/17/2025Sherbrooke Park Advisers LLC13,652$0.74M0.3%-44.7%0.007%Search for SEC Filing on Google Icon
11/17/2025Sittner & Nelson LLC2,800$0.15M0.1%-9.7%0.001%Search for SEC Filing on Google Icon
11/17/2025Polymer Capital Management US LLC21,773$1.18M0.1%+171.7%0.011%Search for SEC Filing on Google Icon
11/17/2025Qube Research & Technologies Ltd260,229$14.09M0.0%-59.4%0.135%Search for SEC Filing on Google Icon
11/17/2025Prelude Capital Management LLC5,317$0.29M0.0%N/A0.003%Search for SEC Filing on Google Icon
11/17/2025Public Employees Retirement System of Ohio60,427$3.27M0.0%+0.9%0.031%Search for SEC Filing on Google Icon
11/17/2025Palo Alto Investors LP754,007$40.84M7.6%-10.3%0.392%Search for SEC Filing on Google Icon
11/17/2025Parkman Healthcare Partners LLC125,949$6.82M0.7%-44.1%0.066%Search for SEC Filing on Google Icon
11/17/2025Northwestern Mutual Wealth Management Co.26,621$1.44M0.0%-1.5%0.014%Search for SEC Filing on Google Icon
11/17/2025Northern Trust Corp1,662,268$90.03M0.0%+0.4%0.865%Search for SEC Filing on Google Icon
11/17/2025Mercer Global Advisors Inc. ADV63,159$3.42M0.0%+88.3%0.033%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.40,409$2.19M0.0%-5.0%0.021%Search for SEC Filing on Google Icon
11/17/2025Larson Financial Group LLC983$53K0.0%-29.7%0.001%Search for SEC Filing on Google Icon
11/17/2025Integrated Wealth Concepts LLC14,490$0.79M0.0%+54.0%0.008%Search for SEC Filing on Google Icon
11/17/2025Holocene Advisors LP5,398$0.29M0.0%-36.3%0.003%Search for SEC Filing on Google Icon
11/17/2025Gotham Asset Management LLC265,332$14.37M0.1%+122.1%0.138%Search for SEC Filing on Google Icon
11/17/2025Fred Alger Management LLC23,700$1.28M0.0%-17.2%0.012%Search for SEC Filing on Google Icon
11/17/2025Focus Partners Wealth27,478$1.49M0.0%+47.9%0.014%Search for SEC Filing on Google Icon
11/17/2025Brevan Howard Capital Management LP22,205$1.20M0.0%N/A0.012%Search for SEC Filing on Google Icon
11/17/2025California Public Employees Retirement System610,275$33.05M0.0%-16.8%0.318%Search for SEC Filing on Google Icon
11/17/2025Bank of Nova Scotia10,808$0.59M0.0%+15.2%0.006%Search for SEC Filing on Google Icon
11/17/2025Boone Capital Management LLC328,546$17.79M5.8%-26.6%0.171%Search for SEC Filing on Google Icon
11/17/2025Boothbay Fund Management LLC11,800$0.64M0.0%-2.5%0.006%Search for SEC Filing on Google Icon
11/17/2025Braidwell LP528,000$28.60M0.8%N/A0.275%Search for SEC Filing on Google Icon
11/17/2025Aquatic Capital Management LLC11,807$0.64M0.0%N/A0.006%Search for SEC Filing on Google Icon
11/17/2025Algert Global LLC40,210$2.18M0.0%+0.8%0.021%Search for SEC Filing on Google Icon
11/17/2025Alliancebernstein L.P.341,791$18.51M0.0%+25.0%0.178%Search for SEC Filing on Google Icon
11/14/2025Schonfeld Strategic Advisors LLC475,398$25.75M0.1%+105.7%0.247%Search for SEC Filing on Google Icon
11/14/2025Creative Planning34,365$1.86M0.0%+49.7%0.018%Search for SEC Filing on Google Icon
11/14/2025Viking Global Investors LP8,322,179$450.73M1.2%-32.3%4.332%Search for SEC Filing on Google Icon
11/14/2025AQR Capital Management LLC5,932,109$321.28M0.2%+6.3%3.088%Search for SEC Filing on Google Icon
11/14/2025Credit Agricole S A7,860$0.43M0.0%N/A0.004%Search for SEC Filing on Google Icon
11/14/2025Bellevue Group AG101,033$5.47M0.1%-33.3%0.053%Search for SEC Filing on Google Icon
11/14/2025Amundi712,887$39.64M0.0%+25.6%0.371%Search for SEC Filing on Google Icon
11/14/2025Deep Track Capital LP24,856$1.35M0.0%N/A0.013%Search for SEC Filing on Google Icon
11/14/2025Caisse de depot et placement du Quebec913,163$49.46M0.1%+43.3%0.475%Search for SEC Filing on Google Icon
11/14/2025Freestone Grove Partners LP476,436$25.80M0.2%+42.0%0.248%Search for SEC Filing on Google Icon
11/14/2025Qtron Investments LLC14,233$0.77M0.1%+18.3%0.007%Search for SEC Filing on Google Icon
11/14/2025Man Group plc1,493,379$80.88M0.1%+1.1%0.777%Search for SEC Filing on Google Icon
11/14/2025California State Teachers Retirement System251,632$13.63M0.0%+5.1%0.131%Search for SEC Filing on Google Icon
11/14/2025Horizon Investments LLC81,538$4.42M0.1%-25.9%0.042%Search for SEC Filing on Google Icon
11/14/2025Zurcher Kantonalbank Zurich Cantonalbank 160,851$8.71M0.0%-61.4%0.084%Search for SEC Filing on Google Icon
11/14/2025Balyasny Asset Management L.P.252,825$13.69M0.0%-42.6%0.132%Search for SEC Filing on Google Icon
11/14/2025UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC1,074,173$58.18M0.0%-18.6%0.559%Search for SEC Filing on Google Icon
11/14/2025Tower Research Capital LLC TRC 9,204$0.50M0.0%+59.2%0.005%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP157,588$8.54M0.0%+6.8%0.082%Search for SEC Filing on Google Icon
11/14/2025Ossiam17,457$0.95M0.0%+8,292.8%0.009%Search for SEC Filing on Google Icon
11/14/2025Towarzystwo Funduszy Inwestycyjnych PZU SA1,051$57K0.0%-38.2%0.001%Search for SEC Filing on Google Icon
11/14/2025NorthRock Partners LLC5,420$0.29M0.0%+11.8%0.003%Search for SEC Filing on Google Icon
11/14/2025Dodge & Cox14,686,801$795.44M0.4%-2.8%7.645%Search for SEC Filing on Google Icon
11/14/2025Glenmede Investment Management LP15,598$0.85M0.0%+27.9%0.008%Search for SEC Filing on Google Icon
11/13/2025Jump Financial LLC110,221$5.97M0.1%-62.2%0.057%Search for SEC Filing on Google Icon
11/13/2025BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp27,563$1.49M0.0%-8.7%0.014%Search for SEC Filing on Google Icon
11/13/2025Aware Super Pty Ltd as trustee of Aware Super405,767$21.98M0.3%+14.3%0.211%Search for SEC Filing on Google Icon
11/13/2025Entropy Technologies LP23,235$1.26M0.1%-19.0%0.012%Search for SEC Filing on Google Icon
11/13/2025Landscape Capital Management L.L.C.19,817$1.07M0.1%-2.3%0.010%Search for SEC Filing on Google Icon
11/13/2025Arrowstreet Capital Limited Partnership374,708$20.29M0.0%+34.5%0.195%Search for SEC Filing on Google Icon
11/13/2025Invesco Ltd.544,396$29.48M0.0%-12.0%0.283%Search for SEC Filing on Google Icon
11/13/2025Connor Clark & Lunn Investment Management Ltd.390,637$21.16M0.1%-3.2%0.203%Search for SEC Filing on Google Icon
11/13/2025Mackenzie Financial Corp175,227$9.49M0.0%+43.6%0.091%Search for SEC Filing on Google Icon
11/13/2025Magnetar Financial LLC12,955$0.70M0.0%-52.4%0.007%Search for SEC Filing on Google Icon
11/13/2025Quadrant Capital Group LLC4,418$0.24M0.0%-63.7%0.002%Search for SEC Filing on Google Icon
11/13/2025Van ECK Associates Corp117,830$6.38M0.0%+6.3%0.061%Search for SEC Filing on Google Icon
11/13/2025Capital Research Global Investors2,537,596$137.44M0.0%+547.5%1.321%Search for SEC Filing on Google Icon
11/13/2025Legal & General Group Plc909,584$49.26M0.0%-14.4%0.473%Search for SEC Filing on Google Icon
11/13/2025Swiss National Bank552,800$29.94M0.0%-4.8%0.288%Search for SEC Filing on Google Icon
11/13/2025WINTON GROUP Ltd123,474$6.69M0.3%+2,835.0%0.064%Search for SEC Filing on Google Icon
11/13/2025Schroder Investment Management Group171,462$9.29M0.0%+85.8%0.089%Search for SEC Filing on Google Icon
11/13/2025Inceptionr LLC25,789$1.40M0.3%-29.5%0.013%Search for SEC Filing on Google Icon
11/13/2025Vinva Investment Management Ltd98,403$5.32M0.1%+216.5%0.051%Search for SEC Filing on Google Icon
11/13/2025Parallel Advisors LLC769$42K0.0%+62.2%0.000%Search for SEC Filing on Google Icon
11/13/2025Meiji Yasuda Asset Management Co Ltd.9,510$0.52M0.0%-2.9%0.005%Search for SEC Filing on Google Icon
11/13/2025Natixis Advisors LLC11,018$0.60M0.0%-56.3%0.006%Search for SEC Filing on Google Icon
11/13/2025Korea Investment CORP519,903$28.16M0.1%+115.2%0.271%Search for SEC Filing on Google Icon
11/13/2025Rhenman & Partners Asset Management AB186,650$10.11M1.1%+24.7%0.097%Search for SEC Filing on Google Icon
11/13/2025Blair William & Co. IL3,957$0.21M0.0%-24.4%0.002%Search for SEC Filing on Google Icon
11/13/2025First Trust Advisors LP894,962$48.47M0.0%+21.2%0.466%Search for SEC Filing on Google Icon
11/12/2025Gabelli Funds LLC29,800$1.61M0.0%+25.2%0.016%Search for SEC Filing on Google Icon
11/12/2025Gamco Investors INC. ET AL13,150$0.71M0.0%+64.4%0.007%Search for SEC Filing on Google Icon
11/12/2025Crossmark Global Holdings Inc.74,158$4.02M0.1%+39.5%0.039%Search for SEC Filing on Google Icon
11/12/2025Dimensional Fund Advisors LP2,245,186$121.60M0.0%+42.7%1.169%Search for SEC Filing on Google Icon
11/12/2025CI Investments Inc.2,424$0.13M0.0%-33.3%0.001%Search for SEC Filing on Google Icon
11/12/2025Focus Partners Advisor Solutions LLC18,612$0.99M0.0%+71.4%0.010%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
BioMarin Pharmaceutical logo
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria (PKU), an inherited metabolic disease. The company's commercial products also comprise Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme, which is delivered through subcutaneous injection to reduce blood Phe concentrations; Brineura, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; Voxzogo, a once daily injection analog of c-type natriuretic peptide for the treatment of achondroplasia; and Aldurazyme, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase. In addition, it develops Roctavian, an adeno associated virus vector, for the treatment of patients with severe hemophilia A. The company serves specialty pharmacies, hospitals, and non-U.S. government agencies, as well as distributors and pharmaceutical wholesalers in the United States, Europe, Latin America, and internationally. BioMarin Pharmaceutical Inc. has license and collaboration agreements with Sarepta Therapeutics, Ares Trading S.A., Catalyst Pharmaceutical Partners, Inc. The company was incorporated in 1996 and is headquartered in San Rafael, California.
Read More on BioMarin Pharmaceutical

Today's Range

Now: $53.82
Low: $53.64
High: $54.66

50 Day Range

MA: $53.87
Low: $51.46
High: $56.29

52 Week Range

Now: $53.82
Low: $50.76
High: $73.51

Volume

1,886,729 shs

Average Volume

2,979,038 shs

Market Capitalization

$10.34 billion

P/E Ratio

20.23

Dividend Yield

N/A

Beta

0.3

Who are the company insiders with the largest holdings of BioMarin Pharmaceutical?

BioMarin Pharmaceutical's top insider shareholders include:
  1. Jean Jacques Bienaime (Director)
  2. Henry J Fuchs (Insider)
  3. Jeffrey Robert Ajer (EVP)
  4. Brian Mueller (CFO)
  5. Charles Greg Guyer (EVP)
  6. George Eric Davis (EVP)
  7. Cristin Hubbard (EVP)
  8. Erin Burkhart (CAO)
Learn More about top insider investors at BioMarin Pharmaceutical.

Who are the major institutional investors of BioMarin Pharmaceutical?

BioMarin Pharmaceutical's top institutional investors include:
  1. Vanguard Group Inc. — 9.67%
  2. Primecap Management Co. CA — 7.93%
  3. Dodge & Cox — 7.64%
  4. Viking Global Investors LP — 4.33%
  5. AQR Capital Management LLC — 3.09%
  6. Capital Research Global Investors — 1.32%
Learn More about top institutional investors of BioMarin Pharmaceutical stock.

Which major investors are selling BioMarin Pharmaceutical stock?

During the previous quarter, BMRN stock was sold by these institutional investors:
  1. Viking Global Investors LP
  2. Assenagon Asset Management S.A.
  3. Primecap Management Co. CA
  4. Dodge & Cox
  5. Voloridge Investment Management LLC
  6. Vanguard Group Inc.
  7. Qube Research & Technologies Ltd
  8. Zurcher Kantonalbank Zurich Cantonalbank
During the previous year, company insiders that have sold BioMarin Pharmaceutical company stock include:
  1. Jean Jacques Bienaime (Director)
  2. Henry J Fuchs (Insider)
Learn More investors selling BioMarin Pharmaceutical stock.

Which major investors are buying BioMarin Pharmaceutical stock?

During the last quarter, BMRN stock was bought by institutional investors including:
  1. Capital Research Global Investors
  2. LSV Asset Management
  3. Dimensional Fund Advisors LP
  4. Pacer Advisors Inc.
  5. Braidwell LP
  6. Krensavage Asset Management LLC
  7. AQR Capital Management LLC
  8. Vestal Point Capital LP